Mapp Lab: New research clarifies how ‘fuzzy’ proteins can be used to develop novel drugs
- News
-
- Search News
-
- Dreyfus-Teacher Scholar Award for Szymczak
- Sanford Named to AAAS
- Biemann Medal for Hakansson
- Sanford Honored with Election to National Academy of Sciences
- McNeil Lab: A more accurate sensor for lead paint
- Schindler Named 2016 Packard Fellow
- Sloan Fellowships for Pratt and Schindler
- Walter Lab: Resolving Subcellular miRNA Trafficking and Turnover at Single-Molecule Resolution
- Maldonado Lab: Cheaper, greener way to grow cystalline semiconductor films
- New polymer allows researchers to study how proteins fold, function
- Researchers focus on cell membranes to develop Alzheimer's treatments
- Video: Research on Lipid Bilayer and Relation to Amyloid-β
- Biteen Lab: Accounting for the "scooching effect"
- Pratt Lab: Molecular Iodine Found in Arctic Atmosphere
- Marsh & McNeil Named AAAS Fellows
- Ramamoorthy Lab: Nanodiscs catch mis-folding amyloid proteins
- Ault Named 2018 Sloan Fellow
- Biteen Lab: Starch Utilization System Assembles around Stationary Starch-Binding Proteins
- Biteen Lab: Starch Utilization System Assembles around Stationary Starch-Binding Proteins
- Pratt & Ault Labs: Harmful algal blooms can become airborne
- Meet Professor Bunsen Burns
- Shedding New Light on Photosynthetic Pigments
- Ruotolo Lab: New Method to ID Proteins
- Energy Research And Education Fuel McCrory CAREER Award
- Building Motors to Drive Nanorobots
- Fast, sensitive mass spectrometer will help UM chemists profile proteins and metabolites
- Award Season for Michigan Chemistry
- Chem Alum Receives Honorary Degree, Gives Rackham Commencement Address
- Alum Named Science Teacher of the Year
- MichiganChem boosts facility for atomic resolution
- DOE Early Career Award for Kerri Pratt
- ACS Honors Alum Weihong Tan
- Michigan Adds Chemistry Education Faculty Position
- Mapp Lab: New research clarifies how ‘fuzzy’ proteins can be used to develop novel drugs
- Karle Symposium Showcases Our Innovative Research
- UM scientists improve synthesis of PET imaging molecules
- MichiganChem Goes to the North Pole
- Diversity Service Award for Nicolai Lehnert
- Two elected Fellows of Royal Society of Chemistry
- Graduate Student Coordinator Honored
- 2018 Mentoring Award Recognizes Unique Programs
- Chen Named AAAS Fellow
- Chem 211 makes organic chem lab real for intro students
- Stephenson Lab: Designing a safer drug building block through photocatalysis
- "Compute-To-Learn" Bridges Classroom to Real-World Experiences
- Meet Roy Wentz: Chemistry's Custom Glassblower
- Michigan Students to Organize American Chemical Society Grad Symposium
- Anna Mapp honored for exceptional efforts to recruit and mentor students from non-traditional backgrounds
- Chemistry Alums Boyd and Pérez-Temprano Named to Talented 12
- Sharing Chemistry with the Community
- Awards Luncheon Offers Recognition for Outstanding Students
- Chemistry Faculty and Staff Collect Honors for Their Work
- Chemistry Writing: More Than Just Lab Reports
- Featured on the UM Gateway: Chemistry D-RISE Alum
- Hot climate, cool science :: Novel instrumentation applied to Arctic atmosphere earns Pratt "40 under 40" honors
- Kennedy Awarded Martin Medal for Achievements in Separation Science
- UM Chemists finding new opportunities in quantum science
- Alumna Sumita Mitra Inducted into National Inventors Hall of Fame
- Walter lab: RNA molecule senses a small metal ion to ramp up bacterium’s detox machine
- Create for Chemistry art contest
- Matzger Lab: A fix for insoluble drugs
- Dope Labs podcast explores the science behind pop culture phenomena
- Travel begets new data and new insights for Michigan Chem grad students
- Kopelman Lab: Nanoparticles + photoacoustic imaging-- a route to better cancer treatment decisions?
- Wang Lab: A productive first year
- National ACS Awards for Four Michigan Faculty
- Montgomery Named Thurnau Professor
- Mental Health, Well-Being and Research
- U-M to 3M: Transitioning to Industry after your PhD
- Chemistry Coping with COVID-19
- Chem Alums Create Crowdfunding Platform
- NSF Graduate Research Fellowships Announced
- Chem Master's Application Re-opened
- Chemistry Awards Announced
- New podcast: "My Fave Queer Chemist”
- Meet Josh Buss
- M|CORE: Preview program lowers barriers to graduate school
- Soellner Joins Michigan Chemistry
- Meet Chem Lecturer Nicole Tuttle
- Making Discoveries, Learning How to Do Research
- Archived News
- UM Chemistry Featured Elsewhere
- Events
Errors in the gene-activation process that arise in a host of human diseases, from cancer to diabetes, have long been considered too “fuzzy” for scientists to target with small-molecule drugs.
But researchers at the University of Michigan have developed a new approach to zero in on the elusive protein-protein interactions where the glitches happen. Their findings, published in Proceedings of the National Academy of Sciences on August 20, open the door to a variety of drug-discovery projects.
Whenever a specific gene needs to be turned on, our bodies build cellular machines to activate the gene, using an assembly of proteins called transcriptional activators and coactivators. Interactions between these two types of proteins are crucial for proper cell function and health.
“Because transcriptional coactivators play such an important role in the process of genes being read — and they are often misregulated in human diseases — many people have been trying to identify drug-like molecules that target these proteins,” explains chemistry professor Anna Mapp, Ph.D., U-M Life Sciences Institute faculty member and senior author on the study. “The problem is, we haven’t really understood the molecular details of these interactions enough to be able to do this.”
Transcription coactivators have what Mapp describes as “fuzzy” structures, which continue to change shape as they bind with various other proteins. This feature enables the cell to use this one component to build many different structures — but it also makes the protein extremely challenging to target, without a clearly defined structure.
Although previous studies have found a few small molecules that can bind to these transcriptional coactivators, none of them were able to bind strongly or have a potent effect on the protein’s activity.
Mapp and her colleagues now have identified one region of a transcriptional coactivator that is critical for its ability to bind to various different structures, and determined that this region can be targeted with drug-like molecules. The researchers have already found one small molecule that binds well to the region and achieves potent interactions in cell cultures, and they are now screening the extensive small-molecule libraries at the LSI’s Center for Chemical Genomics to find other effective molecules.
“We now understand this important class of proteins in a way we didn’t before, which is significant,” says Mapp, who is also the Edwin Vedejs Collegiate Professor of Chemistry in the U-M College of Literature, Science, and the Arts. “But we also have actionable items that we can use to discover more effective drug-like molecules.”
DISCLOSURE & AUTHORSHIP
The research was supported by the National Institutes of Health, the Leukemia and Lymphoma Society and the Department of Education.
Study authors were: Andrew R. Henderson, Matthew J. Henley, Nicholas J. Foster, Amanda L. Peiffer, Matthew S. Beyersdorf, Kevon D. Stanford, Steven M. Sturlis, Brian M. Linhares, Tomasz Cierpicki, Charles L. Brooks III, Carol A. Fierke, and Anna K. Mapp, all of U-M; and Zachary B. Hill and James A. Wells of the University of California, San Francisco.